Mesoblast (MESO) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $161.6 million.
- Mesoblast's Cash & Equivalents rose 15667.09% to $161.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $161.6 million, marking a year-over-year increase of 15667.09%. This contributed to the annual value of $161.6 million for FY2025, which is 15667.09% up from last year.
- As of Q2 2025, Mesoblast's Cash & Equivalents stood at $161.6 million, which was up 15667.09% from $38.0 million recorded in Q4 2024.
- Mesoblast's 5-year Cash & Equivalents high stood at $161.6 million for Q2 2025, and its period low was $38.0 million during Q4 2024.
- Its 5-year average for Cash & Equivalents is $95.0 million, with a median of $81.5 million in 2022.
- In the last 5 years, Mesoblast's Cash & Equivalents crashed by 6434.93% in 2023 and then skyrocketed by 15667.09% in 2025.
- Quarter analysis of 5 years shows Mesoblast's Cash & Equivalents stood at $136.9 million in 2021, then plummeted by 50.6% to $67.6 million in 2022, then increased by 14.69% to $77.6 million in 2023, then crashed by 50.96% to $38.0 million in 2024, then surged by 324.94% to $161.6 million in 2025.
- Its Cash & Equivalents was $161.6 million in Q2 2025, compared to $38.0 million in Q4 2024 and $63.0 million in Q2 2024.